Further, DDIT4 overexpression was associated with worse OS (HR = 1.34 (1.11–1.62), p < 0.01), PPS (HR = 1.43 (1.13–1.8), p < 0.01), DMFS (HR = 1.3 (1.12–1.52), p < 0.001), and RFS (HR = 1.5 (1.35–1.66), p < 0.001) in breast cancer. Here, DDIT4 is linked to breast carcinoma.